Akihiro Mukaino

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Autoimmune postural orthostatic tachycardia syndrome

Mari Watari, Shunya Nakane, Akihiro Mukaino et al. · Annals of Clinical and Translational Neurology · 2018 · 92 citations · Full text

Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients

Shunya Nakane, Osamu Higuchi, Michiaki Koga et al. · PLoS ONE · 2015 · 83 citations · Full text

Immunodeficiencies, Immunology, Clinical Features +19

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis

Hideki Nakajima, Masakatsu Motomura, Keiko Tanaka et al. · BMJ Open · 2015 · 76 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text